Giovanni Di Zenzo

8PUBLICATIONS
49CO-AUTHORS
AllergyAutoimmunityGene expression (incl. microarray and other genome-wide approaches)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 30, 2026
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients.

|Nov 30, 2025
BP230-Type Bullous Pemphigoid is a Rare Subset of Bullous Pemphigoid Associated With a Favorable Prognosis: A Retrospective Analysis From a Tertiary Referral Center.

Roberto Maglie, Sefano Senatore, Carlo Pipitò

|Aug 16, 2025
Autoantibodies to α6 Integrin Subunit Are Detected in a Cohort of Italian Oral Pemphigoid Patients.

Feliciana Mariotti, Anna Pira, Alessandra Rallo

|Jul 04, 2025
Artificial Intelligence Software Changes Rare Disease Testing Strategy in Real Time: An International Case Series Using Face2Gene.

Natasha L Rudy, Adriana Gomes, Tinatin Tkemaladze

|Nov 27, 2024
Broadening the PHIP-Associated Neurodevelopmental Phenotype.

Giulia Pascolini, Giovanni Luca Scaglione, Balasubramanian Chandramouli

|Sep 28, 2024
COVID-19 Vaccine: A Potential Risk Factor for Accelerating the Onset of Bullous Pemphigoid.

Anna Pira, Feliciana Mariotti, Francesco Moro

Pageof 2

Frequent Collaborators

3 joint publications

Feliciana Mariotti

3 joint publications

Anna Pira

2 joint publications

Giovanni Luca Scaglione

2 joint publications

Dario Didona